Anjali Singh

Novo Nordisk in touch with authorities over alleged 1 TB data breach claims

The drugmaker said it is monitoring its systems and maintaining normal operations after reports that a hacking group claimed to have stolen and published company data

Medicover keeps IPO pulse steady as KKR examines India hospital deal

The hospital chain said its planned public listing remains the preferred route even as parent company Medicover AB holds preliminary discussions with KKR

e2W makers ramp up capacity as dealers flag shortages of high-demand models

Electric two-wheeler makers are expanding capacity as rising demand and model-specific shortages lead to longer delivery timelines in several markets

Indian pharma's next prescription: Specialty drugs, not just generics

Indian drugmakers are reducing reliance on US generics, turning to specialty medicines, biosimilars and emerging markets to drive sustainable growth

Cipla expands respiratory, specialty manufacturing across India, China, US

Filed 10 applications with USFDA in FY26 to build a pipeline of differentiated products for regulated markets

Carmakers embrace price hikes to offset rising input, manufacturing costs

Automakers are increasingly opting for smaller, more frequent price increases to offset rising input and manufacturing costs, rather than implementing annual hikes

Generic semaglutide market shows signs of excess inventory bulge

Distributors grapple with rising semaglutide inventory amid slower liquidation

Heatwaves may be causing hidden health stress among working Indians: Study

An analysis of more than 22,000 health records found rising signs of dehydration, electrolyte imbalance and kidney stress among healthy adults during peak summer months

Quest Global flags workplace impact of miscarriage, launches support drive

A study by Quest Global highlights the workplace and career impact of pregnancy loss and calls for structured employer support to improve retention and inclusion

BMW bets on localisation, Tier-2 expansion to double MINI sales in India

The luxury carmaker plans to drive growth through local assembly of the MINI Countryman, expansion into 10 new cities and a broader product portfolio

India's GLP-1 market enters slower growth phase after semaglutide surge

After a near fourfold expansion driven by generic semaglutide launches, India's GLP-1 market is showing signs of moderation as patient onboarding growth slows

Beyond GLP-1, Novo eyes next-gen obesity drugs: Vikrant Shrotriya

Novo Nordisk plans to defend its obesity drug leadership in India as semaglutide patent expiry fuels competition from nearly 50 new market entrants

Uzbekistan eyes Indian pharma firms to achieve $10 bn output by 2035

The Central Asian nation is offering tax breaks, infrastructure support and regulatory incentives as it seeks to become a pharmaceutical manufacturing hub for the CIS region

PM Modi meets Citigroup Chair Jane Fraser, discusses investment plans

The Prime Minister and Citi Chair Jane Fraser discussed investment opportunities, capital flows, artificial intelligence and alternative energy as part of India's long-term growth agenda

Auto component sector margins to moderate amid West Asia conflict: Crisil

Operating margins of auto component makers are expected to decline by up to 150 basis points this fiscal year as higher raw material and freight costs weigh on profitability, according to Crisil

Indian tyre exports hit record high in FY26 despite global challenges

Exports rose 9 per cent to ₹27,312 crore in FY26 as tyre makers expanded into new markets and strengthened manufacturing capacity despite trade and logistics challenges

Alkem launches semaglutide pre-filled syringes in India at ₹350

The company has received DCGI approval for multiple dosage strengths and aims to widen access to semaglutide treatment for diabetes and obesity

Two-wheeler makers post strong May sales on resilient domestic demand

Inventory replenishment, resilient demand for premium models and stronger exports helped India's leading two-wheeler manufacturers record healthy growth in May

Organised aesthetic clinics set to gain from tighter rules on Botox

CDSCO's move can lead to the formalisation of more than 35,000 skin clinics, stop the mushrooming of single-operator setups run by unqualified practitioners

Alkem Q4 profit falls 23% on one-off hit; sees strong FY27 pipeline

The drugmaker said strong domestic branded generics and international business growth helped drive record EBITDA performance in FY26